DeVore Susan D. 4

What Happened Susan D. DeVore, a director of Solventum Corp (SOLV), converted 1,980 restricted stock units (RSUs) into 1,980 shares of common stock on 2026-03-27. The Form 4 shows an "exercise or conversion of derivative (M)" for 1,980 shares acquired at $0.00 and a simultaneous entry for 1,980 shares disposed at $0.00. The filing reports no cash paid for the conversion (price reported $0.00).

Key Details

• Transaction date: 2026-03-27; Form 4 filed: 2026-03-30 (filed within the standard 2 business-day window).
• Reported amounts: 1,980 shares acquired via conversion and 1,980 shares disposed; price per share reported as $0.00 (total consideration shown as $0).
• Shares owned after transaction: not stated in the provided data.
• Footnotes: F1 — each RSU represents a contingent right to receive 1 share upon settlement; F2 — the RSUs were fully vested at settlement.
• Filing timeliness: timely (filed 2026-03-30 for a 2026-03-27 transaction).

Context This entry reflects conversion/settlement of vested RSUs rather than an open-market purchase or a cash exercise of options. A $0.00 per-share exercise price typically indicates share issuance on settlement of RSUs (no cash exercise price). The simultaneous acquisition and disposition can be routine (e.g., settlement mechanics or withholding), but the filing does not specify the reason for the disposition, so no conclusion about DeVore's market view should be drawn.